Previous close | 46.55 |
Open | 47.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 46.89 - 47.73 |
52-week range | 39.47 - 63.74 |
Volume | |
Avg. volume | 413,642 |
Market cap | 9.032B |
Beta (5Y monthly) | 0.60 |
PE ratio (TTM) | 30.04 |
EPS (TTM) | 1.57 |
Earnings date | 24 Jul 2024 |
Forward dividend & yield | 0.50 (1.07%) |
Ex-dividend date | 03 Jul 2024 |
1y target est | 60.50 |
Investing.com -- Shares in Eurofins Scientific (EPA:EUFI) rose on Tuesday, paring back some losses posted in the prior session, after the French laboratory group rejected short seller Muddy Waters' (NYSE:WAT) accusations that it had misrepresented its financial statements.
Muddy Waters said on Monday it had taken a short position in Eurofins shares and published a report saying Eurofins' financial statements could contain material overstatements of profits, cash balances and other asset values. "It is Eurofins' view that the entirety of allegations and insinuations contained therein is either inaccurate, irrelevant, biased and/or misleading," the firm said in a statement. Eurofins "is completely confident in the integrity of its accounts, operational performance, internal controls and risk management", it said.
LUXEMBOURG, June 25, 2024--Regulatory News: Eurofins (Paris:ERF):